Newstral
Article
The Salt Lake Tribune on 2015-04-22 02:42
Teva makes $40.1B unsolicited bid for Mylan
Related news
- Teva ends hostile bid for Mylanbizjournals.com
- Teva makes $40B offer for MylanArkansas Online
- Teva makes unsolicited $82-a-share offer for Mylanbizjournals.com
- Teva makes $40.1-billion unsolicited takeover bid for MylanThe Globe and Mail
- Teva makes unsolicited $40B offer for rival generic drug makerbizjournals.com
- CTeva offers to buy drugmaker Mylan for $40.1Bcontracostatimes.com
- Mylan makes official bid for Perrigoobserver-reporter.com
- Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
- Mylan makes bid for Irish drugmaker Perrigo for $29 billionpost-gazette.com
- Mylan makes official its $30B bid for PerrigoThe Salt Lake Tribune
- Teva offers to buy Mylan in $40.1B cash-and-stock dealdothaneagle.com
- Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com
- FTeva set to lift Mylan bid to up to $43bnft.com
- Teva accuses Mylan of suppressing bidThe Salt Lake Tribune
- Mylan makes $29B offer for Perrigoobserver-reporter.com
- Teva accuses Mylan of ‘desperate attempt’ to suppress bidThe Findlay Courier
- Teva poised to take acquisition bid to Mylan shareholdersbizjournals.com
- Mylan rebuffs Teva again; calls bid low, insinceretimesofisrael.com